Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
ELC Group
ELC Group
Activities:
Regulatory
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
ELC Group in early stage development of novel influenza vaccine
€1m project marks regulatory affairs provider’s entry into the pharmaceutical development market
ELC Group expands into pharmaceutical product development market
Regulatory affairs provider creating extensive product portfolio for sale across US, EU, Latin America, Middle East and North Africa and China
Regulatory
ELC Group signs €1.5m regulatory affairs contract with Chinese pharma company
Endorses its Concept to Commercialisation approach to regulatory affairs consultancy services
Regulatory
ELC Group expands corporate presence in Czech Republic
Major contract wins in China and US fuel latest move into larger premises in Prague
Regulatory
ELC Group appoints Head of Regulatory Affairs for Russia and CIS
Inna Demidova to head new Moscow office for global regulatory affairs specialist
Regulatory
Regulatory review and outlook for 2013 and beyond
<b>28 February - 1 March 2013</b><br> <i>Two-day seminar</i><br> Mumbai, India
Regulatory
ELC Group expands its offices in Ahmedabad, India
Regulatory affairs specialist continues its growth in the country
Subscribe now